Gene to Health Limited primarily focuses on developing multi-omics predictive models for common disease risks, conducting biomedical big data analysis and modeling, and providing bioinformatics research services.

Gene to Health is a pioneer in Asia focused on polygenic scoring technology, leveraging millions of disease-related genetic variants and other omics data to predict over 1000 traits and diseases. Our core product suite, G2H, provides personalized health management solutions in one platform, including risk assessments for chronic diseases, dietary optimization, lifestyle advisory, and cancer risk prediction. We aim to revolutionize disease prevention and improve early disease intervention by integrating advanced genomic analysis, ML and AI.

We focus on developing multi-omics predictive models for common disease risks, conducting biomedical big data analytics and modeling, and offering omic-centered bioinformatics research services.

The primary target industries for our G2H platform are the pan-genomics sector and the general healthcare industries. G2H, with ability to assess disease risks like cardiovascular conditions from omics and health record data, positions it as a valuable tool for medical/genetic testing companies, medical institutions, research labs, and health management companies. Its flexibility allows integration with external datasets for specialized disease prediction, making it ideal for tailored services offered to clients in certain domains like cancer.

We are committed to establishing an integrated smart management platform that combines DNA data, omics data, medical and testing records, wearable device data, and other dynamic health information. Leveraging advancements in genomics and data science, we utilize big data to predict users' lifelong, broad-spectrum health phenotypes and disease risks, while providing personalized health advice and recommendations. This enables users to proactively prevent diseases and enjoy a healthy life.

In addition to serving numerous genetic testing companies, we target young families as our direct users. We drive long-term growth through subscription models, additional purchases, and partnerships with other health service companies. We are also exploring applications in areas such as agriculture, livestock, and the pet industry. Our ultimate goal is to create a broader ecosystem that integrates multiple data sources centered around DNA genetic data, driving diverse precision medicine services.

基因智健有限公司主要緻力於開髮多組學預測模型，以評估常見疾病的風險，進行生物醫學大數據分析和建模，併提供生物信息學研究服務。

基因智健是亞洲的先驅，專註於多基因評分技術，利用數百萬箇與疾病相關的基因變異和其他組學數據，預測超過1000種性狀和疾病。我們的核心産品套件G2H，提供一站式箇性化健康管理解決方案，包括慢性病風險評估、飲食優化、生活方式建議和癌癥風險預測。我們旨在通過整閤先進的基因組分析、機器學習和人工智能，徹底改變疾病預防併提陞早期疾病榦預效果。

我們專註於開髮多組學預測模型，以評估常見疾病的風險，進行生物醫學大數據分析和建模，併提供以組學爲核心的生物信息學研究服務。

G2H平颱的主要目標行業包括泛基因組學領域和通用醫療行業。G2H能夠從組學數據和健康記録中評估心血管疾病等疾病風險，使其成爲醫療/基因檢測公司、醫療機構、研究實驗室和健康管理公司等的寶貴工具。其靈活性使得可以與外部數據集進行整閤，用於特定疾病預測，因此非常適閤爲某些領域如癌癥等提供量身定製的服務。

我們緻力於建立一箇整閤DNA數據、多組學數據、醫療和檢測記録、可穿戴設備數據及其他動態健康信息的智慧管理平颱。通過基因組學和數據科學的進步，我們利用大數據預測用戶的終身健康錶型和疾病風險，併提供箇性化的健康建議與推薦。這使用戶能夠主動預防疾病，享受健康生活。

除瞭爲衆多基因檢測公司提供服務外，我們還將年輕傢庭作爲直接目標用戶。通過訂閲模式、追加購買和與其他健康服務公司閤作，我們推動長期增長。我們也在探索農業、畜牧業和寵物行業等領域的應用。我們的最終目標是創建一箇以DNA基因數據爲核心，整閤多數據源的精準醫學服務生態繫統，推動多樣化的精準醫學服務。